文献速递神经肿瘤功能神经外科

辅助运动区胶质瘤切除:重新审视SMA综合征与额斜束的作用

Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract.
PubMed 文献 · J Neurosurg · 2021-10-01

回顾性分析2010–2019年56例新诊断幕上弥漫性胶质瘤(WHO II–IV级)行SMA区切除术的患者,60.7%术后出现SMA综合征;SMA区切除腔更大者更易出现,切除额斜束(FAT)者全部出现SMA综合征,但保留FAT并不能可靠避免。

要点

  • SMA区切除范围越大、越偏后及累及扣带回,术后SMA综合征风险越高
  • FAT被切除者全部出现SMA综合征,但保留FAT不能可靠避免
  • 出现SMA综合征者住院更长、更常转康复机构,但胶质母细胞瘤总生存无差异

核心结论

  • SMA区更广泛切除及累及后部SMA区和后扣带回增加术后SMA综合征风险
  • FAT切除者均出现SMA综合征,但保留FAT不能可靠避免SMA综合征

研究设计与样本

  • 加州大学旧金山分校肿瘤登记库回顾性研究,2010–2019年新诊断幕上弥漫性胶质瘤(WHO II–IV级)行SMA区切除、随访至少3个月者共56例
  • 复习术前术后MRI确认肿瘤位于SMA区,以体积测量判定SMA切除范围,并将肿瘤配准至标准脑图谱制作频率热图

主要发现

  • 56例中60.7%术后出现SMA综合征
  • SMA区肿瘤体积与SMA综合征发生无关,出现综合征者SMA区切除腔更大(25.4% vs 14.2%,p = 0.039)
  • 切除腔大小与SMA综合征严重程度无关;出现综合征者切除腔更偏SMA后部并累及扣带回
  • 保留FAT者50%出现SMA综合征,FAT离断者100%出现(p = 0.06)
  • 出现SMA综合征者住院更长(5.6 vs 4.1天,p = 0.027)、更常转康复机构(41.9% vs 0%,p < 0.001);新诊断胶质母细胞瘤伴与不伴SMA综合征总生存无差异(1.6 vs 3.0年,p = 0.33)

临床怎么用

  • 术前可依据SMA区计划切除范围(尤其后部SMA区与后扣带回)及FAT是否受累预判SMA综合征风险并用于医患沟通
  • 术后SMA综合征患者需关注较长住院时间与康复转诊需求

局限性

  • 单中心回顾性研究,样本量56例
  • FAT保留与离断比较的p = 0.06未达统计学显著

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The supplementary motor area (SMA) is an eloquent region that is frequently a site for glioma, or the region is included in the resection trajectory to deeper lesions. Although the clinical relevance of SMA syndrome has been well described, it is still difficult to predict who will become symptomatic. The object of this study was to define which patients with SMA gliomas would go on to develop a postoperative SMA syndrome. METHODS: The University of California, San Francisco, tumor registry was searched for patients who, between 2010 and 2019, had undergone resection for newly diagnosed supratentorial diffuse glioma (WHO grades II-IV) performed by the senior author and who had at least 3 months of follow-up. Pre- and postoperative MRI studies were reviewed to confirm the tumor was located in the SMA region, and the extent of SMA resection was determined by volumetric assessment. Patient, tumor, and outcome data were collected retrospectively from documents available in the electronic medical record. Tumors were registered to a standard brain atlas to create a frequency heatmap of tumor volumes and resection cavities. RESULTS: During the study period, 56 patients (64.3% male, 35.7% female) underwent resection of a newly diagnosed glioma in the SMA region. Postoperatively, 60.7% developed an SMA syndrome. Although the volume of tumor within the SMA region did not correlate with the development of SMA syndrome, patients with the syndrome had larger resection cavities in the SMA region (25.4% vs 14.2% SMA resection, p = 0.039). The size of the resection cavity in the SMA region did not correlate with the severity of the SMA syndrome. Patients who developed the syndrome had cavities that were located more posteriorly in the SMA region and in the cingulate gyrus. When the frontal aslant tract (FAT) was preserved, 50% of patients developed the SMA syndrome postoperatively, whereas 100% of the patients with disruption of the FAT during surgery developed the SMA syndrome (p = 0.06). Patients with SMA syndrome had longer lengths of stay (5.6 vs 4.1 days, p = 0.027) and were more likely to be discharged to a rehabilitation facility (41.9% vs 0%, p < 0.001). There was no difference in overall survival for newly diagnosed glioblastoma patients with SMA syndrome compared to those without SMA syndrome (1.6 vs 3.0 years, p = 0.33). CONCLUSIONS: For patients with SMA glioma, more extensive resections and resections involving the posterior SMA region and posterior cingulate gyrus increased the likelihood of a postoperative SMA syndrome. Although SMA syndrome occurred in all cases in which the FAT was resected, FAT preservation does not reliably avoid SMA syndrome postoperatively.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Young JS, Gogos AJ, Aabedi AA, et al. Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract. J Neurosurg. 2021. PMID: 34598138. doi:10.3171/2021.4.JNS21187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。